JAMES MITCHELL: Open Payments
NPI 1295411965 · GOOSE CREEK, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 58 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $560 · 2025 $1,598
Food & beverage: $1,598
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $336 |
| Novo Nordisk Inc | 6 | $311 |
| ABBVIE INC. | 13 | $256 |
| Cagent Vascular INC | 1 | $144 |
| PFIZER INC. | 8 | $141 |
| Corcept Therapeutics | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Exact Sciences Corporation | 2 | $37 |
| Astellas Pharma US Inc | 1 | $31 |
Products named: Ozempic, VRAYLAR, Serrantor, BREZTRI, FARXIGA, AIRSUPRA, ELIQUIS, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
